• SENSEX
    NIFTY 50
Business

Betting big on anti-pneumonia, anti-urinary infection drug, says Wockhardt’s Khorakiwala

Updated : April 20, 2020 03:39 PM IST

WCK 6777 is Wockhardt’s sixth antibiotic drug under development, and will shortly enter phase 1 of clinical trials.
It will be another 3-4 years before the drug can be filed with USFDA for commercial use.
Betting big on anti-pneumonia, anti-urinary infection drug, says Wockhardt’s Khorakiwala

You May Also Like

Live TV

recommended for you

Advertisement